In the first half year of 2021, Symrise AG has performed outstandingly well. In spite of the ongoing coronavirus pandemic across the world, the company’s sales and earnings increased substantially. According to the company, organic sales growth amounted to 9.7%. In the reporting currency – without portfolio and currency translation effects – sales increased by 4.8% to € 1.908 bn (H1 2020: € 1.821 bn). Earnings before interest, taxes, depreciation and amortization (EBITDA) rose by 6.8% to € 420 m compared to the same period of the previous year. The EBITDA margin developed particularly well with a value of 22.0% (H1 2020: 21.6%). Net income for the period increased by 15.9% to € 196 m. Against the background of the good performances during the first half of the year, Symrise raised the forecast for the full year and is targeting organic sales growth of more than 7% (previously 5 to 7%) and an EBITDA margin of more than 21% (previously around 21%).

“The progress made in combatting the worldwide coronavirus pandemic had a positive impact on our business during the second quarter. Demand increased significantly in many areas. In particular there was strong demand for cosmetics and fine fragrance applications again. Product solutions for beverages and food also developed very dynamically because falling case numbers for the coronavirus fueled out-of-home consumption,” commented Dr. Heinz-Jürgen Bertram, CEO of Symrise AG. “Although the pandemic will persist, we are very confident for the coming months following the good first half of the year, and we are more confident about our performance in the future. We are therefore raising our forecast for the organic sales target, as well as for the profitability target.”